MARKET WIRE NEWS

Reflect Scientific Secures Over $1 Million in Follow-On Orders for B-90 Blast Freezer

MWN-AI** Summary

Reflect Scientific, Inc. (Symbol: RSCF), based in Orem, Utah, has announced that it has secured over $1 million in follow-on orders for its B-90 blast freezer, marking a significant milestone in the company's ongoing growth trajectory. This announcement, made on September 29, 2025, underscores the increasing adoption of the B-90 by key sectors such as biopharmaceuticals and cold-chain logistics, where precision in freezing technology is crucial.

The B-90 blast freezer is designed for rapid freezing, offering efficiency and reliability to industries that require stringent temperature control for product integrity. Kim Boyce, CEO of Reflect Scientific, expressed optimism regarding the repeat orders, noting that they reflect the lasting value the B-90 provides to customers. Boyce emphasized the company's commitment to growing its presence in high-demand markets and reinforcing its technological advantage through cryogenic solutions.

As global demand for reliable cold-chain refrigeration solutions continues to rise, Reflect Scientific is strategically positioned to capture new market opportunities while bolstering its financial performance. The company developing and marketing innovative cryogenic technologies has a solid portfolio that includes not only low-temperature freezers but also refrigeration systems tailored for laboratories, transportation, and medical applications.

Reflect Scientific's recent success illustrates the effectiveness of its product offerings and strategic initiatives, potentially translating into long-term value for shareholders. Investors and industry observers will likely monitor the company's progress as it navigates the evolving landscape of the biotechnology and cold-chain logistics sectors. For more information, Reflect Scientific encourages interested parties to visit their website or follow them on social media platforms.

MWN-AI** Analysis

Reflect Scientific, Inc. (RSCF) has announced the receipt of follow-on orders exceeding $1 million for its B-90 blast freezer, indicating a robust demand for its advanced cryogenic cooling solutions. This development underscores the company's innovative position within high-growth industries such as biopharmaceuticals and cold-chain logistics, where quick and reliable freezing technology is vital.

The growing adoption of the B-90 freezer can be viewed as a strong indicator of Reflect Scientific's competitive edge. The B-90's capacity to rapidly freeze products aligns with the increasing global demand for efficient cold-chain solutions, particularly as biopharmaceuticals continue to shift towards more complex therapies requiring stringent handling protocols. Such demand is expected to escalate in the context of an aging population and the continuous rise in health awareness.

From an investment perspective, the momentum showcased by Reflect Scientific suggests potential for both growth and stability. The company's commitment to expanding into new markets while demonstrating its technology's value to customers and shareholders signals a proactive approach to risk management and revenue diversification.

Moreover, given the strategic importance of reliable cold-storage solutions, RSCF is positioned to capitalize on market trends favoring sustainability and efficiency in logistics. Investors should watch for further announcements related to product development and market expansions, which could bolster the company’s financial outlook.

However, it is essential to remain cautious. While the current news is promising, the market is subject to uncertainties, such as competitive pressures and supply chain disruptions. Potential investors should balance their enthusiasm with a thorough analysis of the company’s financial health and market conditions before making investment decisions. As Reflect Scientific leverages its technology effectively, RSCF may present a compelling opportunity in the cryogenic solutions space.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

OREM, Utah, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic cooling solutions, today announced it has received follow-on orders totaling more than $1 million for its B-90 blast freezer. This milestone highlights growing customer adoption and continued momentum for one of the company’s flagship products.

The B-90 blast freezer is engineered to rapidly freeze products, providing speed, efficiency, and reliability for industries where precision matters most. Customers include biopharmaceuticals and cold-chain logistics companies—sectors with strong growth potential that rely on dependable freezing technology.

"Securing over $1 million in repeat orders is a strong signal that our B-90 blast freezer delivers lasting value to customers," said Kim Boyce, CEO of Reflect Scientific, Inc. "We are committed to building on this success as we expand into high-growth markets and continue demonstrating how our cryogenic technology can drive long-term shareholder value."

With global demand increasing for reliable cold-chain and preservation solutions, Reflect Scientific is well-positioned to capture new opportunities while delivering consistent results to its customers and investors.

About Reflect Scientific, Inc.

Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific .

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”


ContactInvestor Relations801-607-1039info@reflectscientific.com

FAQ**

How does Reflect Scientific Inc RSCF plan to leverage the recent follow-on orders for the B-90 blast freezer to strengthen its market position in the biopharmaceutical and cold-chain logistics sectors?

Reflect Scientific Inc (RSCF) aims to leverage recent follow-on orders for the B-90 blast freezer by enhancing its product offerings, increasing production capacity, and bolstering customer relationships to strengthen its competitive position in the biopharmaceutical and cold-chain logistics markets.

What specific strategies is Reflect Scientific Inc RSCF implementing to expand into high-growth markets and enhance shareholder value based on its recent $1 million success in orders?

Reflect Scientific Inc. is leveraging its recent $1 million in orders to strategically invest in innovative product development, enhance marketing efforts to penetrate high-growth markets, and strengthen partnerships to boost sales and shareholder value.

In light of increasing global demand for cold-chain solutions, what innovations or improvements can we expect from Reflect Scientific Inc RSCF to maintain its competitive edge in cryogenic technology?

Reflect Scientific Inc. (RSCF) is likely to focus on advancements in thermal insulation materials, enhanced energy efficiency, IoT integration for real-time monitoring, and automated systems to improve reliability and reduce costs in its cryogenic solutions to maintain a competitive edge.

How does Reflect Scientific Inc RSCF intend to mitigate risks associated with its forward-looking statements, particularly regarding the anticipated growth in the application of its cryogenic cooling solutions?

Reflect Scientific Inc. (RSCF) plans to mitigate risks associated with forward-looking statements by employing comprehensive market analysis, robust operational strategies, and adaptive management to navigate uncertainties in the anticipated growth of its cryogenic cooling solutions application.

**MWN-AI FAQ is based on asking OpenAI questions about Reflect Scientific Inc (OTC: RSCF).

Reflect Scientific Inc

NASDAQ: RSCF

RSCF Trading

0.0% G/L:

$0.0466 Last:

3,462 Volume:

$0.0466 Open:

mwn-alerts Ad 300

RSCF Latest News

RSCF Stock Data

$3,991,946
40,005,128
51.34%
1
N/A
Medical Equipment & Supplies
Healthcare
US
Orem

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App